These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35278135)

  • 1. Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.
    Buurman DJM; Willemsen ACH; Speksnijder CM; Baijens LWJ; Hoeben A; Hoebers FJP; Kessler P; Schols AMWJ
    Support Care Cancer; 2022 Jun; 30(6):5329-5338. PubMed ID: 35278135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
    Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
    Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
    Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
    BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
    Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dental Extractions Before Radiation Therapy and the Risk of Osteoradionecrosis in Patients With Head and Neck Cancer.
    Lee J; Hueniken K; Cuddy K; Pu J; El Maghrabi A; Hope A; Hosni A; Glogauer M; Watson E
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1130-1139. PubMed ID: 37856115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?
    Chang DT; Sandow PR; Morris CG; Hollander R; Scarborough L; Amdur RJ; Mendenhall WM
    Head Neck; 2007 Jun; 29(6):528-36. PubMed ID: 17230555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
    Sher DJ; Yan J; Day A; Sumer BD; Pham NL; Khan S; Zhu H
    Oral Oncol; 2019 Jan; 88():18-26. PubMed ID: 30616791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy-associated dental extractions and osteoradionecrosis.
    Beech NM; Porceddu S; Batstone MD
    Head Neck; 2017 Jan; 39(1):128-132. PubMed ID: 27473832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
    de Roest RH; van der Heijden M; Wesseling FWR; de Ruiter EJ; Heymans MW; Terhaard C; Vergeer MR; Buter J; Devriese LA; de Boer JP; Navran A; Hoeben A; Vens C; van den Brekel M; Brakenhoff RH; Leemans CR; Hoebers F
    Radiother Oncol; 2022 Oct; 175():112-121. PubMed ID: 35973619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.
    Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Bourhis J; Deutsch E; Daly-Schveitzer N; Tao Y
    Strahlenther Onkol; 2014 Sep; 190(9):823-31. PubMed ID: 24638267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis : A systematic review and meta-analysis.
    Balermpas P; van Timmeren JE; Knierim DJ; Guckenberger M; Ciernik IF
    Strahlenther Onkol; 2022 Mar; 198(3):219-228. PubMed ID: 35029717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Guo TW; Saiyed F; Yao CMKL; Kiong KL; Martinez J; Sacks R; Lee JJ; Moreno AC; Frank SJ; Rosenthal DI; Glisson BS; Ferrarotto R; Mott FE; Johnson FM; Myers JN
    Cancer; 2021 Aug; 127(16):2916-2925. PubMed ID: 33873251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of osteoradionecrosis of the jaws: a retrospective study of 620 patients with head and neck cancer.
    Kabir R; Durand R; Roberge D; Dufresne E; Nguyen-Tân PF
    Gen Dent; 2022; 70(4):72-77. PubMed ID: 35749251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tooth extraction prior to radiotherapy for oropharyngeal cancer increases the risk of osteoradionecrosis.
    Slettvoll S; Thaning RC; Pedersen TØ
    J Oral Sci; 2023 Mar; 65(2):87-89. PubMed ID: 36858604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between dental extraction after radiotherapy and osteoradionecrosis: A multi-centre retrospective study.
    Saito I; Hasegawa T; Kawashita Y; Kato S; Yamada SI; Kojima Y; Ueda N; Umeda M; Shibuya Y; Kurita H; Kirita T; Akashi M
    Oral Dis; 2022 May; 28(4):1181-1187. PubMed ID: 33650256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
    Shirasu H; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Mori K; Yasui H
    BMC Cancer; 2020 Mar; 20(1):182. PubMed ID: 32131771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
    Buurman DJM; Speksnijder CM; Granzier ME; Timmer VCML; Hoebers FJP; Kessler P
    Radiother Oncol; 2023 Oct; 187():109847. PubMed ID: 37543058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
    Yilmaz B; Somay E; Selek U; Topkan E
    Ther Clin Risk Manag; 2021; 17():1113-1121. PubMed ID: 34703240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.